RY 176.35 -0.3841% SHOP 167.99 -0.7151% TD 82.75 0.2544% ENB 64.05 0.0% BN 88.32 1.6107% TRI 241.54 0.9909% CNQ 44.115 0.7652% CP 113.63 -0.342% CNR 151.81 0.2774% BMO 145.19 0.408% BNS 75.07 -0.0399% CSU 4740.3501 0.4989% CM 92.68 -0.2368% MFC 43.88 0.9664% ATD 75.94 0.0132% NGT 59.47 -0.1008% TRP 65.46 0.2911% SU 55.67 1.0895% WCN 263.59 0.0835% L 185.08 0.3198%
Company Overview: Global Atomic Corp. (TSX: GLO) is an interesting player in the resource sector, with its dual focus on high-grade uranium mine development and cash-flowing zinc concentrate production. Unicycive Therapeutics Inc. (NASDAQ: UNCY) is a biotechnology company specializing in developing innovative therapies for kidney diseases and related medical conditions. The Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Global Markets Wrap-Up
On January 23, 2025, the S&P 500 index settled at 6118.71 with a week till date gain of 1.15%; moreover, the tech-heavy NASDAQ composite advanced by ~2.16% on a WTD basis and settled at 20053.68. While the Russell 2000 settled at 2314.60, reflecting a gain of ~1.70% on a WTD basis.
Considering the Canadian market, the benchmark S&P/TSX Venture Composite Index (TSX: ^JX) started the week on a positive note and continued the momentum. On January 23, 2025, the index closed at 616.94 with an overall week-to-date (WTD) gain of 0.10%. Energy and healthcare were the leading sectors, while consumer non-cyclicals, real estate, consumer cyclicals, technology, basic materials and Industrials were the laggards on Thursday.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA 
AU
UK
US
NZ
Please wait processing your request...